1. Home
  2. AMST vs AEON Comparison

AMST vs AEON Comparison

Compare AMST & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amesite Inc.

AMST

Amesite Inc.

N/A

Current Price

$2.12

Market Cap

11.8M

Sector

Technology

ML Signal

N/A

Logo AEON Biopharma Inc.

AEON

AEON Biopharma Inc.

HOLD

Current Price

$1.02

Market Cap

10.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMST
AEON
Founded
2017
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
10.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
AMST
AEON
Price
$2.12
$1.02
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.20
AVG Volume (30 Days)
492.9K
167.7K
Earning Date
02-09-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$193,505.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
68.56
N/A
52 Week Low
$2.00
$0.38
52 Week High
$5.18
$45.29

Technical Indicators

Market Signals
Indicator
AMST
AEON
Relative Strength Index (RSI) 38.39 59.04
Support Level $2.05 $0.72
Resistance Level $2.75 $1.12
Average True Range (ATR) 0.19 0.10
MACD -0.01 0.03
Stochastic Oscillator 7.89 77.53

Price Performance

Historical Comparison
AMST
AEON

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

About AEON AEON Biopharma Inc.

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Share on Social Networks: